Effectiveness of Dry Needling in Shortened Triceps Surae Muscle

Myofascial Pain Syndrome Clinical Trial

— DN-TS  

Official title:

Effectiveness of Deep Dry Needling in Subjects With Shortened Triceps Surae Originated by Myofascial Pain Syndrome

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03273985
• Other study ID #: DN-TS-UCM
• Status: Completed
• Phase: N/A
• First received: September 1, 2017
• Last updated: December 6, 2017
• Start date: September 15, 2017
• Est. completion date: December 6, 2017

Study information

• Verified date: December 2017
• Source: Universidad de León
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To date, there are not studies about the effectiveness of dry needling versus ischemic compression in the triceps surae trigger points. A randomized clinical trial is carried out. A sample of 30 subjects are recruited and allocated into dry needling (n = 15) and ischemic compression (n = 15). Outcome measurements such as dorsal flexion range of motion, plantar pressures, temperature, superficial muscle activity and trigger points pressure pain threshold are measured immediately before and after treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: December 6, 2017
• Est. primary completion date: December 6, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Myofascial pain syndrome in the triceps surae muscle, limitation of ankle dorsal flexion range of motion.

Exclusion Criteria:

• Neurologic disorders, pharmacologic treatment (within the previous 3 months), cognitive impairment, prosthesis in the lower limb, systemic or infectious diseases, autoimmune diseases, fibromyalgia, hypothyroidism, anticoagulants or antiplatelet agents, and fear of needles.

Related Conditions & MeSH terms

• Fibromyalgia
• Myofascial Pain Syndrome
• Myofascial Pain Syndromes
• Syndrome
• Trigger Point Pain, Myofascial

Intervention

Other:
• Dry needling
Trigger point deep dry needling
• Ischemic compression
Trigger point ischemic compression

Locations

Country	Name	City	State
Spain	Fisiofuenla	Fuenlabrada	Madrid

Sponsors (2)

Lead Sponsor	Collaborator
Universidad de León	Universidad Complutense de Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Range of motion	Ankle dorsal flexion by means of the goniometer	Change from Baseline Range of motion at 25 minutes
Secondary	Plantar pressures	Plantar pressures platform	Change from Baseline Plantar pressures at 25 minutes
Secondary	Temperature	Thermal imaging	Change from Baseline Temperature at 25 minutes
Secondary	Superficial muscle activity	Electromyography	Change from Baseline Superficial muscle activity at 25 minutes
Secondary	Pressure pain threshold	Algometer	Change from Baseline Pressure pain threshold at 25 minutes